Benzinga | Nov 19, 2021 05:36AM EST

BMO Capital Initiates Coverage On Eli Lilly with Outperform Rating, Announces Price Target of $311

BMO Capital analyst Evan Seigerman initiates coverage on Eli Lilly (NYSE:LLY) with a Outperform rating and announces Price Target of $311.